Clinical Trials Browser

Phase 1/2 × INDUSTRY × mirdametinib × Clear all

NCT05580770 2025-02-17

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor